French Try Plane Technology in Artificial Heart Oct 30, 2008
The most advanced U.S. artificial heart, made by the U.S. company Abiomed, sells for up to $250,000. Abiomed was aware of the French project but declared itself ahead in the race ... On average, Abiomed's heart has extended patients' lives by about five months. (Time.com)
EADS Has A Heart Oct 28, 2008
Artificial hearts are nothing new: AbioMed (nasdaq: - - ) implanted its first replacement heart unit in 2001, and as far back as the 1980s the considerably more cumbersome Jarvik 7 was unveiled to the public ... The devices' battery life is also a rather short five hours, though this does not compare badly with AbioMed's four-hour rechargeable battery pack. (Forbes -- Markets)
Tiny Propeller in Heart May Save Lives Aug 26, 2008
The Impella device has been in use in Europe for several years, but the pharmaceutical company ABIOMED, along with cardiologist Dr. William O'Neill of the University of Miami, is hoping to bring it to the United States to help patients in need of heart operations. 1. (ABC News)
Dunkin' Donuts offers a healthier menu brand Jul 31, 2008
Abiomed expands with lease for plant in Ireland Abiomed Inc. is expanding into Ireland, the Danvers medical device firm said. Abiomed said it has signed a long-term operating lease for a manufacturing facility in Athlone, Ireland, and expects its Impella blood pump production line to be operational there in about 18 months ... 5 cardiac assist device from the Abiomed facility in Aachen, Germany. (Boston Globe)
Abiomed receives FDA OK for Impella blood pump Jun 3, 2008
THE REGION Abiomed Inc. said it has received Food and Drug Administration approval for selling a blood pump. The Danvers medical device company said it was cleared to sell the Impella 2. (Boston Globe)
AG finds utility acted lawfully, but was remiss May 22, 2008
Abiomed Inc. reported a wider-than-expected fiscal fourth-quarter loss due to a surge in expenses. The Danvers medical device maker lost $15 million, or 46 cents a share, compared with $6. (Boston Globe)
Fast forward: five to thrive May 20, 2008
REPLACEMENT ORGANS Abiomed Inc. of Danvers has received international attention for its plastic-and-titanium replacement heart, the AbioCor. A second generation of the product, 30 percent smaller than the original and designed to operate inside a patient for as long as five years, could begin human trials soon. (Boston Globe)
Nasdaq and Toronto Stock Exchange warn World Heart May 18, 2008
Last week World Heart said its "primary potential investor" may not be able to give it enough money to cover a $5 million loan from If World Heart, which has cash and equivalents of $500,000, defaults on the loan, Abiomed may foreclose on the company's assets. World Heart only has enough money to keep operating until the end of this month. (San Francisco Business Journal)
WorldHeart Reports an Event of Default Under the Note Issued to Abiomed, Resignation of One of Its Board of Directors, and Results of Shareholder Vote at Its Annual Shareholders' Meeting May 10, 2008
0 million issued on December 11, 2007 to Abiomed, Inc. This event of default under the note results in the outstanding principal balance of the note, together with accrued but unpaid interest and any other amounts owing under the Abiomed note documents, becoming immediately due and payable to Abiomed. The note is secured by security agreements entered into by the Company and the Company's wholly-owned subsidiary, World Heart, Inc. ("WHI"), in favor of Abiomed, that grant a security interest in... (PR Newswire)
Beer party ends in assault and arrest May 2, 2008
Just before 10 p.m. Saturday, police were dispatched to the woods behind Abiomed after a call came into the station about a fire. Officers Ashley Berube, Phil Tansey and Scott Frost responded. (Danvers Herald, MA)
Abiomed developing second-generation artificial heart Apr 10, 2008
Scott Corbett shows of the Abiocor and Abiocor II, two artificial hearts produced by Abiomed of Danvers ... Of course, it was an artificial heart, the Abiocor, manufactured by Abiomed in Danvers and recently approved for sale ... Abiomed was established in 1981 and headquartered in Danvers, where 330 people work. (Danvers Herald, MA)
Thoratec pump jumps over heart pioneer Robert Jarvik Mar 31, 2008
With FDA approval, Thoratec will have nearly a two-year jump against Jarvik Heart Inc., AbioMed Inc. and other competitors that are developing their own lighter, smaller and quieter heart implants, said CEO Gary Burbach. And Burbach doesn't intend to squander the opening. (East Bay Business Times, CA)
Life Sciences 25 Jan 28, 2008
Local Search Site Search. THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING. (Boston Globe)
Hospital Pulls Out Of Tests Of Artificial Heart Jan 26, 2008
Jewish Hospital is absent from the list of four hospitals selected by Abiomed, maker of the AbioCor device, as sites for the next surgeries to implant the device in critically ill patients. The list includes the Texas Heart Institute at St. Luke's Episcopal Hospital in Houston. (KWTX.com, TX)
Jewish Hospital stops performing AbioCor implants Jan 26, 2008
She said the hospital will continue to participate in research studies with AbioMed at the Cardiovascular Innovation Institute, a heart research facility run by Jewish Hospital & St. Mary's HealthCare and the University of Louisville. Related Industry News. (Louisville Business First, KY)
Sox uniforms to sport EMC logo during Japan games Jan 23, 2008
THE REGIONFDA OK's upgrades to Abiomed's AbioCor device Medical device maker Abiomed says the Food and Drug Administration has approved system upgrades to its AbioCor implantable replacement heart. The device replaces severely damaged hearts in patients not eligible for a transplant or other treatments. (Boston Globe)
Hopkins Hospital to begin implanting AbioCor replacement hearts Jan 23, 2008
"This is a momentous day for Abiomed and advanced heart failure patients who cannot recover their natural heart or receive a transplant. We have selected leading U.S. hospitals committed to the AbioCor program and expect patient implants with AbioCor to commence in early 2008," said Michael Minogue, chief executive officer of Abiomed in a statement ... Abiomed expects to charge $250,000 per AbioCor unit in a controlled roll out at up to five U.S. centers. (Baltimore Business Journal, MD)
AG fines delivery company for misclassifying drivers Dec 20, 2007
FDA clears Abiomed to sell iPulse circulatory system Abiomed Inc., a Danvers medical device company, said it has received approval from the Food and Drug Administration to sell its combination iPulse Circulatory Support System. The iPulse drives Abiomed and other manufacturers' intra-aortic balloons as well as products Abiomed may offer, the company said. (Boston Globe)
WorldHeart Announces Strategic Alliance with Abiomed Dec 12, 2007
Abiomed's extensive and experienced field support and marketing team is well positioned to promote and support WorldHeart's products ... They are well respected in the field of circulatory support and have an extensive network of loyal heart surgeons," commented Michael R. Minogue, Chairman, President and Chief Executive Officer of Abiomed. "Based on the analysis of our top scientists, and our due diligence with leading customers, we believe that the Levacor mag-lev rotary pump represents the... (Canada Newswire)
Abiomed Announces Strategic Investment in WorldHeart Corporation Dec 12, 2007
DANVERS, MASS., December 12 /CNW/ - Abiomed, Inc. (NASDAQ: ABMD), a leading provider of medical devices that provide circulatory support to acute heart failure patients today announced a strategic investment in WorldHeart Corporation (NASDAQ: WHRT, TSX: WHT), a developer of implantable mechanical circulatory support systems for chronic heart failure patients. Under the terms of the transaction, Abiomed has agreed to loan $5 million in convertible secured debt to WorldHeart, with a term of two... (Canada Newswire)
Medical device makers make pitch to investors Nov 1, 2007
One publicly traded company, Abiomed Inc. of Danvers, is scheduled to make a presentation. But most of the firms are smaller privately held companies, including. (Boston Globe)
SAP's Business Objects deal: Opportunities, pitfalls Oct 10, 2007
"If the acquisition gives us better or cheaper access to some of those it'll be of great benefit to Abiomed as we look for more ways to mine and utilize the data we collect in SAP." ... "If the acquisition gives us better or cheaper access to some of those it'll be of great benefit to Abiomed as we look for more ways to mine and utilize the data we collect in SAP.". (Search SAP)
Sense of urgency for spinal device Sep 18, 2007
of Natick, Stryker Biotech in Hopkinton, and Abiomed Inc. in Danvers have all won such exemptions in the past. In the case of Abiomed, the publicly traded company was granted a waiver a year ago to sell its Abiocor artificial heart to patients who are not candidates for conventional heart transplant surgery ... "It's a very positive thing for patients," said Michael R. Minogue, Abiomed's chief executive. (Boston Globe)
HealthShares(TM) Announces Quarterly Rebalancing of HealthShares(TM) Indexes Sep 18, 2007
4 Abiomed Inc ABMD 224655053. 7 Cardiac Science Corp. CSCX 251191110. (PR Newswire)
Abiomed gets FDA OK to test new circulatory support system Sep 4, 2007
Abiomed Inc. has received conditional approval from the U.S. Food and Drug Administration to begin a clinical trial in the United States for the Impella(R) 2 ... -based Abiomed (Nadsdaq: ABMD) posted a net loss of $27. (Boston Business Journal, MA)
Abiomed expects FDA OK for blood-pumping device Aug 30, 2007
Abiomed Inc. moved a step closer to winning federal approval for a blood pump ... Abiomed acquired the Impella technology when it bought Impella CardioSystems AG for $45 million two years ago. (Boston Globe)
Abiomed Receives Conditional FDA Approval for Impella 2.5 Pivotal Study at up to 150 Hospitals Aug 30, 2007
Abiomed Receives Conditional FDA Approval for Impella 2 ... --(BUSINESS WIRE)--Abiomed, Inc. (NASDAQ: ABMD) today announced it has received conditional approval from the U.S. Food and Drug Administration (FDA) to begin its pivotal clinical trial in the United States for the Impella 2 ... 5 as compared to optimal medical management, stated Michael R. Minogue, Chairman, President and CEO of Abiomed. (BusinessWire)
ASUG president gets full-time gig Aug 30, 2007
-based Abiomed, perhaps best summed up the feelings of SAP customers and users ... -based Abiomed, perhaps best summed up the feelings of SAP customers and users. (Search SAP)
Device helps patients survive, regain function til transplant Aug 30, 2007
The center also offers extracorporeal membrane oxygenation (ECMO), the Thoratec and original HeartMate ventricular assist devices, the Novacor ventricular assist device, the Orqis and TandemHeart devices that are attached to the circulatory system outside the body, and the Abiomed device. Soon, they will begin recruiting patients for clinical trials of the Duraheart and Levacor rotary ventricular assist devices. (EurekAlert!)
Mailers union approves 5-year pact with Globe Jul 4, 2007
Arbitrator rules against Abiomed in Penn St. case Abiomed Inc. said an arbitrator has ruled that the medical-device company breached its agreement with some of its warrant holders by temporarily canceling a program at Pennsylvania State University ... 50 shares of Abiomed common stock for a penny a share, according to a filing with the Securities and Exchange Commission ... The arbitrator also ruled that Danvers-based Abiomed should pay $504,604 to reimburse the claimants for legal and... (Boston Globe)
Sapphire 2007: SAP, Microsoft make nice with Duet Apr 25, 2007
ATLANTA -- Now that the first round of have provided feedback, SAP and Microsoft yesterday announced new features and a long-range roadmap for the software that allows users to tap into SAP applications through their familiar Microsoft Office applications. 0 of Duet will be delivered in late 2008 and will integrate Microsoft SharePoint Server as a Duet extension. (Search SAP)
Business in brief Apr 24, 2007
New job: Abiomed Inc. named David Weber chief operating officer, a new position at the Danvers company, which makes medical devices. Abiomed said Weber most recently was employed as general manager of aviation and transportation business. (Boston Globe -- Business)
SAP license negotiations: Beware of shelfware Apr 12, 2007
-based Abiomed, a midsized medical device company, negotiated its contract with SAP, Dan Lubin, the company's director of information technology, led the charge with assistance from general counsel ... Abiomed's Lubin agreed that negotiation can be a time-consuming process ... -based Abiomed, a midsized medical device company, negotiated its contract with SAP, Dan Lubin, the company's director of information technology, led the charge with assistance from general counsel. (Search SAP)
SOA: SAP to offer standardized processes Mar 22, 2007
At its annual Sapphire user conference on April 22, SAP will release standard processes aimed at providing guidance and structure for companies implementing and managing service-oriented architecture (SOA) plans. Dubbed solution operation standards by SAP, they will contain best-practice procedures on how to run the individual processes and explain how SAP Solution Manager tools can be used. (Search SAP)
SAP keeps artificial heart manufacturer pumping Mar 15, 2007
When Abiomed realized its existing systems would not be sufficient for its growth push, the company turned to SAP. ... "Did it do the job? Yes," Daniel Lubin, Abiomed's director of information technology, said ... -based Abiomed develops, manufactures and markets medical products designed to assist or replace the pumping function of a failing heart. (Search SAP)
Wednesday's Stocks to Watch Mar 14, 2007
Abiomed Inc. () said it plans to offer 5 million shares in an underwritten public offering. The underwriters will be granted an option to purchase up to an additional 750,000 shares to cover over-allotments, the Danvers, Mass. (Fox News)
Utility rate plan will cut average bills $32 year Feb 6, 2007
Increased marketing, hiring widen Abiomed loss Danvers cardiac device maker Abiomed Inc. said its third-quarter loss widened 49 percent with the expansion of the sales force and marketing activities. The loss grew to $6. (Boston Globe)
RX For Wrong-site Surgery: Two Minutes Of Conversation Jan 25, 2007
(July 6, 2001) -- A Jewish Hospital clinical team led by University of Louisville surgeons Laman A. Gray, Jr., M.D., and Robert D. Dowling, M.D., successfully implanted ABIOMED, Inc.'s AbioCor replacement heart in a. . (Science Daily)
